Communicating emerging risks of SGLT2 inhibitors-timeliness and transparency of medicine regulators. - Search Results

Save citations to file

Email citations

Your saved search

Your RSS Feed

Communicating emerging risks of SGLT2 inhibitors-timeliness and transparency of medicine regulators.

Bhasale A, Mintzes B, Sarpatwari A. Bhasale A, et al. BMJ. 2020 Apr 29;369:m1107. doi: 10.1136/bmj.m1107. BMJ. 2020. PMID: 32349976 No abstract available.

Communicating emerging risks of SGLT2 inhibitors-timeliness and transparency of medicine regulators.

[No authors listed] [No authors listed] BMJ. 2020 May 4;369:m1745. doi: 10.1136/bmj.m1745. BMJ. 2020. PMID: 32366378 No abstract available.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

Search Page

Search Results